Crimson staff writer

Thamini Vijeyasingam

Latest Content


Napster Sparks Debate About Music Piracy at Harvard

When Napster was founded in May 1999, students across the country jumped at the opportunity to download their favorite music without the hassle of buying a new CD. But for universities, the novel technology posed a new problem: legal threats from the music industry.


New Cancer Hospital for Dana Farber Leaves Healthcare Experts Skeptical

When the Dana Farber Cancer Institute announced that it was opening a new, $1.7 billion, 300-bed inpatient cancer hospital in 2028 along with Beth Israel Deaconess Hospital, the announcement seemed to promise good news for the region. But healthcare experts aren’t so sure.


FDA Layoffs, Funding Cuts Cast Shadow Over Biopharma Industry

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon expected to pull back from the biotech industry, representing a blow to a primary engine of the Boston area’s economic growth.


Biogen to Move Global Headquarters to Kendall Commons in 2028

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new building in Kendall Square in 2028, consolidating its various branches and operations into a single “innovation hub” while drawing the company still closer to nearby MIT.


Biotech Giant Roche Launches Innovation Center on Harvard’s Allston Research Campus

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced on Thursday that it will establish an Innovation Center on Harvard’s Enterprise Research Campus in Allston. The Swiss multinational company is leasing 30,000 square feet of space from the ERC’s 1.9 million square feet,and plans to eventually employ up to 500 employees.